MPM Capital Raises Biotech’s Largest Impact Investment Fund to Help Finance the Fight Against Cancer and Other Diseases

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct 6, 2021– Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF 2” or “the Fund”), making it the world’s largest biotech impact investment fund.

Read the source article at businesswire.com
2021-10-06 01:00:00